Smartest Doc
Reassessment of Declines in Pulmonary Function 1 Year or More after Stereotactic Body Radiotherapy (SBRT)
Chest, 06/26/2012
Takeda A et al. – Declines in FEV1 and FVC were small, but statistically significant in patients with normal function or mild–moderate COPD, however, non–significant in patients with severe COPD. These declines were primarily due to physiologic aging. Stereotactic body radiation therapy (SBRT) had a limited effect on decline in long–term pulmonary function and may be an acceptable alternative to surgery for patients with comorbid lung cancer and COPD.
